Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

OWL

Market Reaction to OWL Stock Decline

This afternoon we watched Blue Owl Capital drop -2.6% to a price of $16.08 per share. The Large-Cap Asset Management company is now trading -28.42% below its average target price of $22.46. Analysts have set target prices ranging from $18.0 to $28.0 per share for Blue Owl Capital, and have given the stock an average rating of buy.

Blue Owl Capital has an average level of shares sold short, at 6.9% of its total share float. The stock's short ratio (also called days to cover) is 5.49. At 0.04%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.

Institutional investors own 95.7% of Blue Owl Capital's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Blue Owl Capital

Date Reported Holder Percentage Shares Value
2025-06-30 Capital World Investors 13% 84,073,355 $1,351,899,541
2025-06-30 Vanguard Group Inc 10% 62,948,362 $1,012,209,656
2025-06-30 Capital International Investors 9% 60,584,461 $974,198,128
2025-06-30 Blackrock Inc. 7% 45,217,166 $727,092,025
2025-06-30 FMR, LLC 7% 43,873,007 $705,477,949
2025-06-30 ICONIQ Capital, LLC 5% 33,500,000 $538,679,997
2025-06-30 Bank of America Corporation 3% 20,812,929 $334,671,896
2025-06-30 Morgan Stanley 2% 13,504,045 $217,145,042
2025-06-30 Geode Capital Management, LLC 2% 10,293,279 $165,515,925
2025-06-30 JPMORGAN CHASE & CO 2% 9,904,618 $159,266,256
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS